A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash

Publication date: September 2017
Source:Journal of the American Academy of Dermatology, Volume 77, Issue 3
Author(s): Viswanath R. Belum, Michael A. Marchetti, Stephen W. Dusza, Andrea Cercek, Nancy E. Kemeny, Mario E. Lacouture




http://ift.tt/2fBIkfN